Tuesday, July 11, 2006

Timothy Leary back from the grave

Independent Online Edition > Health Medical

A very odd story this:

Forty years after Timothy Leary, the apostle of drug-induced mysticism, urged his hippie followers to "tune in, turn on, and drop out", researchers at Johns Hopkins University, in Baltimore, Maryland, have for the first time demonstrated that mystical experiences can be produced safely in the laboratory.... For the US study, 30 middle-aged volunteers who had religious or spiritual interests attended two eight-hour drug sessions, two months apart, receiving psilocybin in one session and a non-hallucinogenic stimulant, Ritalin, in the other. They were not told which drug was which.
Note in bold the first thing to question about this study.

One third described the experience with psilocybin as the single most spiritually significant of their lifetimes and two thirds rated it among their five most meaningful experiences. In more than 60 per cent of cases the experience qualified as a "full mystical experience" based on established psychological scales, the researchers say. Some likened it to the importance of the birth of their first child or the death of a parent. The effects persisted for at least two months. Eighty per cent of the volunteers reported moderately or greatly increased well-being or life satisfaction. Relatives, friends and colleagues confirmed the changes.

Ooh, sounds all so inspiring. But then:

A third of the volunteers became frightened during the drug sessions with some reporting feelings of paranoia. The researchers say psilocybin is not toxic or addictive, unlike alcohol and cocaine, but that volunteers must be accompanied throughout the experience by people who can help them through it.

I just find it incredibly hard to believe that they could ever overcome the unreliability of such "therapy". Wasn't there enough work done on using hallucinogenic and other mind altering drugs (such as ecstacy) in the 1940's to 1960's to see that this is not a worthwhile way to go?

No comments: